Gabapentin, another anticonvulsant drug commonly used for focal epilepsies has been demonstrated to activate HCN channels (Surges et al., 2003) again opening the therapeutic opportunity to address overactive bladder in epileptic patients simultaneously. The gene discussed is MALAT1; the disease is focal epilepsy.